We are live on ! Find out more

168 hedge funds and large institutions have $658M invested in CareDx in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 54 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 54

1.81% more ownership

Funds ownership: 106.27%108.08% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 182168 (-14)

32% less capital invested

Capital invested by funds: $962M → $658M (-$304M)

37% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 35

94% less call options, than puts

Call options by funds: $91K | Put options by funds: $1.51M

Holders
168
Holders Change
-14
Holders Change %
-7.69%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
67
Reduced
54
Closed
35
Calls
$91K
Puts
$1.51M
Net Calls
-$1.42M
Net Calls Change
-$1.72M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$4.88M -$793K -53,544 -11%
Charles Schwab
27
Charles Schwab
California
$4.81M +$118K +7,937 +2%
Morgan Stanley
28
Morgan Stanley
New York
$4.57M +$2.67M +179,949 +82%
Norges Bank
29
Norges Bank
Norway
$4.57M +$404K +27,237 +7%
SAM
30
Silvercrest Asset Management
New York
$4.02M -$2.22M -150,067 -30%
JP Morgan Chase
31
JP Morgan Chase
New York
$3.9M +$1.65M +111,437 +48%
N
32
Nuveen
North Carolina
$3.75M -$561K -37,853 -10%
UBS Group
33
UBS Group
Switzerland
$3.71M +$4.13M +278,593 +604%
First Eagle Investment Management
34
First Eagle Investment Management
New York
$3.1M +$875K +59,034 +28%
T. Rowe Price Associates
35
T. Rowe Price Associates
Maryland
$3.06M -$2.07M -139,962 -34%
RCAMU
36
Rothschild & Co Asset Management US
Connecticut
$3.04M -$268K -18,095 -6%
Barclays
37
Barclays
United Kingdom
$2.91M +$1.02M +68,900 +37%
Two Sigma Investments
38
Two Sigma Investments
New York
$2.65M -$4.01M -270,801 -54%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$2.63M -$10.2K -689 -0.3%
Citadel Advisors
40
Citadel Advisors
Florida
$2.57M -$3.36M -226,589 -50%
Citigroup
41
Citigroup
New York
$2.51M -$753K -50,815 -19%
Mirae Asset Global Investments
42
Mirae Asset Global Investments
South Korea
$2.48M -$759K -51,208 -19%
Legal & General Group
43
Legal & General Group
United Kingdom
$2.1M +$565K +38,149 +26%
Assenagon Asset Management
44
Assenagon Asset Management
Luxembourg
$2.05M +$938K +63,275 +55%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$1.99M -$194K -13,125 -7%
EAM
46
EFG Asset Management
Oregon
$1.94M +$215K +14,524 +9%
CSS
47
Cubist Systematic Strategies
Connecticut
$1.93M -$987K -66,628 -28%
TI
48
Trexquant Investment
Connecticut
$1.69M +$1.42M +95,655 +182%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.47M +$43K +2,900 +2%
ETC
50
Exchange Traded Concepts
Oklahoma
$1.4M +$556K +37,539 +44%

CDNA Hedge Fund Activity: Q4 2022 in Review

168 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q4 2022, worth a combined $658M — down 32% from $962M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of CDNA and 22 opened new positions — a net loss of 13 holders — while 54 trimmed existing stakes and 67 added.

The largest buyer was State Street, adding an estimated $22.2M. The largest seller was ClearBridge Investments, exiting entirely with an estimated $28.3M sold.

  • 168 institutional investors held CareDx (CDNA) as of Q4 2022, down from 182 in Q3 2022.
  • Funds reported $658M of CareDx stock for Q4 2022, down 32% quarter-over-quarter.
  • 22 funds opened new CareDx positions in Q4 2022 and 35 closed out, a net change of -13 holders.
  • The largest CareDx buyer in Q4 2022 was State Street, an estimated $22.2M added.
  • The largest CareDx seller in Q4 2022 was ClearBridge Investments, an estimated $28.3M sold.

Based on aggregated 13F filings for Q4 2022.